DanielleRArmasMD

Family Medicine • Scottsdale, AZ

Physician

Join to view full profile

Dr. Armas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Armas' full profile

Already have an account?

Office
13737 N 92nd St
Scottsdale, AZ 85260
Phone+1 480-301-8000
Is this information wrong?

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Residency, Family Medicine, 2006 - 2009
Mayo Clinic College of MedicineClass of 2006

Certifications & Licensure

AZ State Medical License 2007 - 2025
American Board of Family Medicine Family Medicine

Awards, Honors, & Recognition

Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2010-2013
Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2010-2013

Clinical Trials

An Inpatient Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects (Study 201) Start of enrollment: 2021 Jul 16
Completed
Phase 2
Roles: Contact
A Study of TAK-227 in Healthy Adults Start of enrollment: 2023 May 25
Completed
Phase 1
Roles: Principal Investigator

Publications & Presentations

PubMed

24 citations
Identifying Patients at Risk for Obstructive Sleep Apnea in a Primary Care Practice
Michael Grover, Martina Mookadam, Danielle Armas, Ciara Bozarth, Tarah Castleberry, Meghan Gannon, Denise Webb, Amylou C. Dueck> ;Journal of the American Board of Family Medicine. 2011 Mar 1

Press Mentions

Xeris Pharmaceuticals Completes Enrollment of Its Phase 1 Study of Levothyroxine (XP-8121)September 1st, 2021
Effects of Rifampin on the Pharmacokinetics of a Single Dose of Istradefylline in Healthy SubjectsSeptember 7th, 2017